Drug intelligence / Profile preview

baqin manyan diwan

Development stage: Unknown
Lead developer: Jilin University Science and Technology Center
Modality: Small Molecules
Administration: Oral

Overview

Baqin Manyan Diwan is a Traditional Chinese Medicine (TCM) dripping pill formulation developed by the Jilin University Science and Technology Center for the treatment of chronic pharyngitis. It is designed to alleviate clinical symptoms such as throat congestion, pain, and dryness. The formulation utilizes the dripping pill technology to improve the dissolution and absorption of its active herbal components, which typically possess anti-inflammatory and antimicrobial properties. It is primarily marketed and used within the Chinese healthcare system for patients suffering from persistent pharyngeal inflammation.

Brand names: Baqin Manyan Diwan
Other names: Baqin Chronic Pharyngitis Dripping PillsBaqin DiwanBa Qin Man Yan Di Wan

Beyond the preview

Go deeper on baqin manyan diwan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on baqin manyan diwan.

Explore the full profile